ID: ALA2208333

Max Phase: Preclinical

Molecular Formula: C23H30N6O4

Molecular Weight: 454.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O

Standard InChI:  InChI=1S/C23H30N6O4/c1-33-19-12-6-5-10-16(19)21(31)28-17(11-7-13-27-23(25)26)22(32)29-18(20(24)30)14-15-8-3-2-4-9-15/h2-6,8-10,12,17-18H,7,11,13-14H2,1H3,(H2,24,30)(H,28,31)(H,29,32)(H4,25,26,27)/t17-,18-/m0/s1

Standard InChI Key:  HCHKOIZJWXHBPQ-ROUUACIJSA-N

Associated Targets(Human)

Neuropeptide FF receptor 2 533 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neuropeptide FF receptor 1 514 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 454.53Molecular Weight (Monoisotopic): 454.2329AlogP: 0.27#Rotatable Bonds: 12
Polar Surface Area: 172.42Molecular Species: BASEHBA: 5HBD: 6
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 8#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.28CX Basic pKa: 11.74CX LogP: 0.02CX LogD: -2.07
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.15Np Likeness Score: -0.26

References

1. Gealageas R, Schneider S, Humbert JP, Bertin I, Schmitt M, Laboureyras E, Dugave C, Mollereau C, Simonnet G, Bourguignon JJ, Simonin F, Bihel F..  (2012)  Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors.,  22  (24): [PMID:23131340] [10.1016/j.bmcl.2012.10.049]

Source